Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients.
Rasha EletrebyWafaa ElakelMohamed SaidMohamed El KassasSameh SeifTamer ElbazMaissa El RazikySiham Abdel RehimSamy ZakyRabab FouadHadeel Gamal EldeenMahmoud AbdoMohamed KoranyAyman YosryMagdy El SerafyManal Hamdy El-SayedYehia ElShazlyImam WakedWahid DossGamal EsmatPublished in: Liver international : official journal of the International Association for the Study of the Liver (2016)
Sofosbuvir/Simeprevir combination is an effective and well tolerated regimen for patients with chronic HCV genotype IV.